神经病理性疼痛药物处方、依从性与停药预测因素的系统综述与荟萃分析
该系统综述与荟萃分析纳入 69 项研究,其中处方相关 53 项、依从性相关 14 项、停药相关 27 项,旨在识别成人神经病理性疼痛患者药物处方、依从性和停药的预测因素。结果显示,精神障碍、糖尿病和白人种族与更可能被处方推荐药物相关;使用血清素-去甲肾上腺素再摄取抑制剂、剂量滴定和用药提醒与更好依从性相关;使用三环类抗抑郁药和联合用药与更高停药可能性相关。
要点
- 精神障碍、糖尿病和白人种族与更可能被处方推荐神经病理性疼痛药物相关
- 使用血清素-去甲肾上腺素再摄取抑制剂、剂量滴定和用药提醒与更好依从性相关
- 使用三环类抗抑郁药和联合用药与更高停药可能性相关
核心结论
- 需重点关注少数族裔和无糖尿病患者的神经病理性疼痛药物处方改善。
- 剂量滴定和用药提醒可提高依从性。
- 单药治疗而非联合用药可能带来更好的治疗持续性。
研究设计与样本
- 系统综述与荟萃分析,检索 Embase、PubMed、Web of Science 和 CINAHL Plus。
- 纳入 69 项相关研究,分为处方 53 项、依从性 14 项、停药 27 项(非互斥分类)。
主要发现
- 与更可能被处方推荐药物相关的因素包括精神障碍、糖尿病和白人种族。
- 与更好依从性相关的因素包括使用血清素-去甲肾上腺素再摄取抑制剂(对比加巴喷丁类或三环类抗抑郁药)、剂量滴定和实施用药提醒。
- 与更高停药可能性相关的因素包括使用三环类抗抑郁药(对比其他抗抑郁药)和联合用药(对比单药治疗)。
临床怎么用
- 对少数族裔和无糖尿病患者应关注推荐药物的处方不足问题。
- 可通过剂量滴定和用药提醒提高患者依从性。
- 优先考虑单药治疗而非联合用药以改善治疗持续性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharmacoepidemiological studies show that large proportions of people with neuropathic pain are not prescribed the recommended medications, do not adhere well to these medications, and often discontinue the treatment within 6 months. Identifying what predicts these outcomes can inform a strategy to ensure that people with neuropathic pain are prescribed recommended medication and continue their treatment when appropriate. METHODS: We carried out a systematic review and meta-analysis to identify predictors of pain medication prescribing, adherence, and discontinuation in adults with neuropathic pain. Electronic searches were conducted in Embase, PubMed, Web of Science, and CINAHL Plus. RESULTS: We identified 69 relevant studies and divided them into non-mutually exclusive categories based on the outcomes they had investigated. There were 53 studies on prescribing, 14 on adherence, and 27 on discontinuation. Predictors associated with being prescribed recommended neuropathic pain medications included having a mental health disorder, diabetes mellitus, and White race. Predictors associated with better adherence included being prescribed serotonin-norepinephrine reuptake inhibitors compared with gabapentinoids or tricyclic antidepressants, dose titration, and implementing a medicine reminder. Predictors associated with a higher likelihood of discontinuation included being prescribed tricyclic antidepressants rather than other antidepressants and having a combination of neuropathic pain medications rather than monopharmacotherapy. CONCLUSIONS: There is a need to focus on improving neuropathic pain medication prescribing for ethnic minorities and people without diabetes mellitus. Adherence can be improved by using dose titration and medicine reminders. Prescribing monopharmacotherapy rather than combination pharmacotherapy for neuropathic pain could result in better treatment persistence. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023464307).
引用
- Koponen ME, Senaratne DNS, Hébert HL, et al. Identifying predictors of neuropathic pain medication prescribing, adherence, and discontinuation: a systematic review and meta-analysis. Br J Anaesth. 2025. PMID: 41314943. doi:10.1016/j.bja.2025.10.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。